Difference between revisions of "WSI22-23-Case-14"
From MGH Learn Pathology
(requisition -> sequence) |
(Added status template) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
{{ServiceRequestCase | {{ServiceRequestCase | ||
| − | |subject= | + | |subject=MGH |
|intent=order | |intent=order | ||
|category=409073007 | |category=409073007 | ||
| Line 11: | Line 11: | ||
|locationCode=learn | |locationCode=learn | ||
|sequence=14 | |sequence=14 | ||
| − | |performer= | + | |performer=MM768 |
|occurrenceDateTime=2022/02/01 12:00 | |occurrenceDateTime=2022/02/01 12:00 | ||
|reasonCode=A 55-year-old man with Melanoma on anti-PD-1/CTLA-4 combination developed diarrhea and abdominal pain. Clinical work-up showed an elevated tTG IgA titer (121 IU/mL). | |reasonCode=A 55-year-old man with Melanoma on anti-PD-1/CTLA-4 combination developed diarrhea and abdominal pain. Clinical work-up showed an elevated tTG IgA titer (121 IU/mL). | ||
|supportingInfo=Immune checkpoint inhibitor (ICI)-associated duodenitis | |supportingInfo=Immune checkpoint inhibitor (ICI)-associated duodenitis | ||
| + | |access=public | ||
}} | }} | ||
{{Media | {{Media | ||
| Line 35: | Line 36: | ||
|view=show | |view=show | ||
|modality=mrxs | |modality=mrxs | ||
| + | }} | ||
| + | {{status | ||
| + | |status=active | ||
| + | |requester=Mm768 | ||
| + | |authoredOn=February 04, 2022 06:23:37 PM | ||
}} | }} | ||
Latest revision as of 14:35, December 9, 2024
